表 2. Analysis of the baseline demographic and clinical data of the patients.
患者基线临床资料比较
| Variable | MBT (n=198) |
NMBT (n=409) |
P |
| BMI: body mass index; ASA: American Society of Aneshesiologists; PLT: platelet count; INR: international normalized ratio; PT: prothrombin time; APTT: activated partial thromboplastin time; ALT: alanine transaminase; AST: aspartate transaminase; TBIL: total bilirubin; DBIL: direct bilirubin; ALB: albumin. | |||
| Sex/case (%) | 0.21 | ||
| Male | 131 (66.16) | 291 (71.15) | |
| Female | 67 (33.84) | 118 (28.85) | |
Age/yr., 
|
47.36±11.29 | 46.12±14.10 | 0.28 |
| Ethnicity/case (%) | 0.81 | ||
| Han Chinese | 167 (84.34) | 349 (85.33) | |
| Minority ethnicities | 31 (15.66) | 60 (14.67) | |
BMI/(kg/m2), 
|
22.18±3.44 | 22.61±3.57 | 0.17 |
| Primary disease/case (%) | 0.11 | ||
| Hepatocellular carcinoma | 98 (49.50) | 204 (49.88) | |
| Cirrhosis | 73 (36.87) | 150 (36.67) | |
| Hepatic failure | 22 (11.11) | 45 (11.00) | |
| Congenital immunodeficiency diseases |
5 (2.52) | 10 (2.45) | |
| History of abdominal surgery/case (%) | 0.34 | ||
| No | 109 (55.05) | 242 (59.17) | |
| Yes | 89 (44.95) | 167 (40.83) | |
| ASA score/case (%) | 0.42 | ||
| 1 | 8 (4.04) | 16 (3.91) | |
| 2 | 57 (28.79) | 145 (35.45) | |
| 3 | 130 (65.66) | 241 (58.92) | |
| 4 | 3 (1.51) | 7 (1.72) | |
| Operation duration/case (%) | 0.29 | ||
| <3 h | 7 (3.54) | 20 (4.89) | |
| ≥3 h | 191 (96.46) | 389 (95.11) | |
PLT/109 L－1, 
|
97.97±72.00 | 103.27±94.81 | 0.04 |
INR ( ) |
1.48±0.70 | 1.04±0.08 | <0.01 |
PT/s, 
|
16.36±6.96 | 11.51±0.81 | <0.01 |
APTT/s, 
|
39.51±16.69 | 28.53±3.35 | <0.01 |
ALT/(U/L), 
|
334.33±16.64 | 138.94±46.02 | <0.01 |
AST/(U/L), 
|
81.78±43.01 | 246.54±88.42 | <0.01 |
TBIL/(μmol/L), 
|
53.83±7.69 | 40.80±11.42 | <0.01 |
DBIL/(μmol/L), 
|
39.10±5.02 | 31.22±10.50 | <0.01 |
ALB/(g/L), 
|
34.19±5.72 | 32.96±5.12 | 0.13 |
| Child-Pugh grade/case (%) | 0.73 | ||
| A | 13 (6.57) | 15 (3.67) | |
| B | 70 (35.35) | 136 (33.25) | |
| C | 115 (58.08) | 258 (63.08) | |